News Digest / Ticker: CNBX

Ticker: CNBX

10:01am, Monday, Jul 14, 2025

CNBX Pharmaceuticals Faces Financial Struggles Amid Cuts and Hope for Clinical Trials

CNBX Pharmaceuticals Inc. (OTCBB: CNBX) Overview CNBX Pharmaceuticals is a pre-clinical-stage biopharmaceutical company focused on developing innovative therapies, particularly for oncology and colorectal cancer. As of the latest report for the quarter ended May 31, 2025, CNBX continues to face o...

10:00am, Monday, Apr 14, 2025

CNBX Pharmaceuticals Faces Financial Challenges Despite Some Positive Trends in Latest Report

CNBX Pharmaceuticals Inc. (OTCBB: CNBX) is currently navigating significant financial challenges and operational changes as detailed in their latest quarterly report for the period ending February 28, 2025. Financial Highlights: Total Assets: $50,660 (up from $31,385 as of August 31, 2024) Curre...